MaxCyte Inc (NAS:MXCT)

Q1 2026 MaxCyte Inc Earnings Call Transcript

May 12, 2026 / 08:30 PM GMT

Release Date Price: $0.8222 (+0.65%)

Transcript 10-Q8-K

Key Points

Positve

MaxCyte Inc (MXCT) reported $9.7 million in total revenue for Q1 2026, meeting expectations.
The company saw a 25% increase in SPL program-related revenue compared to the previous year.
MaxCyte Inc (MXCT) has a strong balance sheet with $147.7 million in cash equivalents and no debt.
The company announced a $10 million share repurchase program, indicating confidence in its long-term value.
The launch of the Xper DTX product is progressing well, with early traction in various markets, including academic centers and large pharma.

Negative

Total revenue decreased by 7% compared to Q1 2025, driven by a decline in core revenue.
Core revenue fell by 25% year-over-year, impacted by inventory management issues and discontinued SPL programs.
Gross margin decreased to 84% from 86% in the previous year, with non-GAAP adjusted gross margin also declining.
The company is not forecasting any additional SPL milestones for 2026, indicating potential revenue stagnation.
Challenges in the cell and gene therapy ecosystem persist, particularly for earlier-stage clinical programs.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MXCT.OQ - MaxCyte Inc
Q1 2026 MaxCyte Inc Earnings Call
May 12, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day, and thank you for standing by. Welcome to the MagSight First Quarter Earnings Conference Call. At this time, all participants are on the listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press *11 on your telephone. You will then hear an automated message advising your hand is raised. Please note that today's conference is being recorded. I will now hand the conference over to your speaker host, Eric Abdul, of Invest Relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.